These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14709953)

  • 41. An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy.
    Schwartz TL; Azhar N; Cole K; Hopkins G; Nihalani N; Simionescu M; Husain J; Jones N
    J Clin Psychiatry; 2004 Sep; 65(9):1223-7. PubMed ID: 15367049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD; Bodkin JA
    J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
    Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
    Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An open-label, flexible-dose study of memantine in major depressive disorder.
    Ferguson JM; Shingleton RN
    Clin Neuropharmacol; 2007; 30(3):136-44. PubMed ID: 17545748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modafinil for remitted bipolar depression with hypersomnia.
    Fernandes PP; Petty F
    Ann Pharmacother; 2003 Dec; 37(12):1807-9. PubMed ID: 14632587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Symptoms of fatigue and sleepiness in major depressive disorder.
    Baldwin DS; Papakostas GI
    J Clin Psychiatry; 2006; 67 Suppl 6():9-15. PubMed ID: 16848671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial.
    Lundorff LE; Jønsson BH; Sjøgren P
    Palliat Med; 2009 Dec; 23(8):731-8. PubMed ID: 19648224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors.
    Konuk N; Atasoy N; Atik L; Akay O
    Adv Ther; 2006; 23(4):646-54. PubMed ID: 17050507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.
    Möller F; Poettgen J; Broemel F; Neuhaus A; Daumer M; Heesen C
    Mult Scler; 2011 Aug; 17(8):1002-9. PubMed ID: 21561959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modafinil augmentation of antidepressant treatment in depression.
    Menza MA; Kaufman KR; Castellanos A
    J Clin Psychiatry; 2000 May; 61(5):378-81. PubMed ID: 10847314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series.
    Bouwer C; Claassen J; Dinan TG; Nemeroff CB
    Depress Anxiety; 2000; 12(1):44-50. PubMed ID: 10999245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.
    Ondo WG; Fayle R; Atassi F; Jankovic J
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1636-9. PubMed ID: 16291885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A follow-up study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis.
    Hardy T; MacDonald C; Jones DE; Newton JL
    Liver Int; 2010 Nov; 30(10):1551-2. PubMed ID: 20536714
    [No Abstract]   [Full Text] [Related]  

  • 54. Interaction of modafinil and clomipramine as comedication in a narcoleptic patient.
    Grözinger M; Härtter S; Hiemke C; Griese EU; Röschke J
    Clin Neuropharmacol; 1998; 21(2):127-9. PubMed ID: 9579300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modafinil treatment for fatigue in HIV+ patients: a pilot study.
    Rabkin JG; McElhiney MC; Rabkin R; Ferrando SJ
    J Clin Psychiatry; 2004 Dec; 65(12):1688-95. PubMed ID: 15641875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis.
    Sheng P; Hou L; Wang X; Wang X; Huang C; Yu M; Han X; Dong Y
    PLoS One; 2013; 8(12):e81802. PubMed ID: 24312590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structured cues or modafinil for fatigue amelioration in clinicians? A double-blind, randomized controlled trial of critical clinical information recall in fatigued clinicians.
    Flindall I; Leff DR; Goodship J; Sugden C; Darzi A
    Surgery; 2016 Apr; 159(4):1181-90. PubMed ID: 26520004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia.
    Rosenthal MH; Bryant SL
    Clin Neuropharmacol; 2004; 27(1):38-43. PubMed ID: 15090936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder.
    Stahl SM; Zhang L; Damatarca C; Grady M
    J Clin Psychiatry; 2003; 64 Suppl 14():6-17. PubMed ID: 14658930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An open-label trial of modafinil augmentation in patients with partial response to antidepressant therapy.
    Markovitz PJ; Wagner S
    J Clin Psychopharmacol; 2003 Apr; 23(2):207-9. PubMed ID: 12640225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.